RetinaLyze Blog

Learn what’s new in Optometry, Ophthalmology and RetinaLyze.

RetinaLyze, a leader in AI-driven eye screening and tele-ophthalmology, today announced a strategic cooperation with Rockmed Vision to make accessible, high-quality retinal screening available to more patients and providers across the Benelux (the Netherlands, Belgium, and Luxembourg).
Record-keeping is a legal obligation. It’s also the single most important piece of evidence if a case is reviewed by a complaints or disciplinary body.
RetinaLyze System A/S, a pioneer in artificial intelligence (AI) and telemedicine solutions for eye care, is excited to announce a strategic partnership with Eyevinci B.V, a leading provider of digital healthcare innovation.
Medibrix, a leading provider of innovative digital healthcare solutions, and RetinaLyze System A/S, a pioneer in AI-based eye screening technology, are proud to announce a new cooperation aimed at improving access to efficient eye health screening through the Medibrix platform.
A 79-year-old patient recently visited an optometrist using RetinaLyze System for a routine eye check. The optometrist noted abnormal findings on both fundus images and OCT scans.
RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a strategic distribution partnership with Bloxx Digital Innovation, a Bloss Group company.
RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for optometry and healthcare, is pleased to announce a strategic distribution partnership with Romger General Trade & Consulting S.R.L.
Copenhagen, Denmark and Bratislava, Slovakia – January 28, 2024 – RetinaLyze System A/S, a leading provider of artificial intelligence (AI) and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a new strategic distribution partnership with Surveye s.r.o
Here is a concise overview of how clinicians can appraise and integrate AI-based technologies such as RetinaLyze into everyday practice.
A thank you and a status to partners, distributors, customers and friends
Copenhagen, Denmark and Brno, Czech Republic – 10.12.2024 – RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a strategic distribution partnership with Medicontur CZ s.r.o.
As we turn the page on 2024, it’s remarkable to look back on the strides we’ve made at RetinaLyze System A/S.
In alignment with World Sight Day 2024's theme “Children, Love Your Eyes,” RetinaLyze has announced the launch of its Advanced Glaucoma Progression AI.
If you're considering adding eye screening services to your practice, there are several important factors to keep in mind.
This update focuses on streamlining workflows for optometrists and enhancing the accessibility of data for both users and external specialists.
As we step into the latter part of the year, it’s the perfect time to reflect on the exciting developments that have unfolded at RetinaLyze in 2024. Our commitment to enhancing eye care through cutting-edge technology has led to several significant advancements that we’re thrilled to share.
We are incredibly grateful for the opportunity to contribute to this significant discussion on the future of health diagnostics through oculomics, as featured in a recent publication called “Is early diagnosis always better” by The College of Optometrists.
RetinaLyze has launched a new version of their fundus analysis software offering a range of improvements designed to streamline workflows and assist in decision-making.
New Ph.D. thesis explores the use of artificial intelligence in screening for diabetic retinal changes in diabetes patients.
Artificial intelligence and eye screening: A topic that has been discussed in recent weeks not only in webinars, but generally in the industry. Those who have not yet had the chance to experience an AI-based eye screening live can do so at any time at OPTI 2023. The algorithms of RetinaLyze allow eye screening using artificial intelligence with fundus cameras or OCT devices.
No more posts to show